Antitrust: Commission fines Teva and Cephalon €60.5 million
Synthon succeeds with Brinkhof and BarentsKrans in jurisidiction claim against Teva - JUVE Patent
DEF 14A
Teva Is Easy Pill to Swallow - WSJ
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Statement by Executive Vice-President Margrethe Vestager on the Commission decision to fine Teva and Cephalon €60.5 million for delaying entry of cheaper generic medicine - PubAffairs Bruxelles
Case studies in Strategy: Teva
Copaxone not dead yet as Teva appeal lives on | Evaluate
Judge Narrows Antitrust Case Against Teva Over Gilead HIV Drugs -
Teva: Pricing In A Worst-Case Copaxone Scenario (NYSE:TEVA) | Seeking Alpha
Case studies in Strategy: Teva
20 States Accuse Generic Drug Companies of Price Fixing - The New York Times
Brussels' Teva probe reveals dark side of patent protections | Financial Times
Men's Original Universal Urban – Sports Basement
Teva Under Suspicion On Practices To Stave Off Copaxone Competition
Teva to Buy Allergan Generics for $40.5 Billion - WSJ
Biden admin urges Supreme Court to hear 'skinny labels' case between Teva, GSK | Reuters
Teva neck-deep in legal trouble with no end in sight | Ctech
Ranbaxy, Teva settle US anti-competition case | Mint
Teva Settles Cephalon Generics Case With F.T.C. for $1.2 Billion - The New York Times
Men's Hurricane XLT2 – Sports Basement
